Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial

BACKGROUND: Patients hospitalized for COVID-19 are at high risk of thrombotic complications and organ failure, and often exhibit severe inflammation, which may contribute to hypercoagulability. OBJECTIVES: To determine whether patients hospitalized for COVID-19 experience differing frequencies of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Walborn, Amanda T., Heath, Anna, Neal, Matthew D., Zarychanski, Ryan, Kornblith, Lucy Z., Hunt, Beverley J., Castellucci, Lana A., Hochman, Judith S., Lawler, Patrick R., Paul, Jonathan D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579532/
https://www.ncbi.nlm.nih.gov/pubmed/37854455
http://dx.doi.org/10.1016/j.rpth.2023.102203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579532/
https://www.ncbi.nlm.nih.gov/pubmed/37854455
http://dx.doi.org/10.1016/j.rpth.2023.102203

Ejemplares similares